Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma by Takafumi Fukushima, Kazuyuki Numakura, Masanao Shinohara, Yohei Kawashima, Yuya Sekine, Kanami Mori, Mizuki Kobayashi, Himawari Asanuma, Takaki Ichiyama, Hisashi Sakurai, Kai Ozaki, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama

Get full text